Verastem Oncology (VSTM) Misses Q2 EPS by 61c

Verastem Oncology (NASDAQ: VSTM) reported Q2 EPS of ($0.61).

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• Syndax Pharmaceuticals (SNDX) PT Lowered to $33 at UBS as Revuforj New Starts Decline
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04